Scott Robertson
2021
In 2021, Scott Robertson earned a total compensation of $2.4M as Chief Business and Financial Officer at DICE Therapeutics, a 294% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $200,000 |
|---|---|
| Option Awards | $1,362,748 |
| Salary | $388,262 |
| Stock Awards | $428,008 |
| Total | $2,379,018 |
Robertson received $1.4M in option awards, accounting for 57% of the total pay in 2021.
Robertson also received $200K in non-equity incentive plan, $388.3K in salary and $428K in stock awards.
Rankings
In 2021, Scott Robertson's compensation ranked 5,353rd out of 12,406 executives tracked by ExecPay. In other words, Robertson earned more than 56.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,353 out of 12,406 | 57th |
Division Manufacturing | 2,251 out of 5,492 | 59th |
Major group Chemicals And Allied Products | 981 out of 2,368 | 59th |
Industry group Drugs | 873 out of 2,089 | 58th |
Industry Pharmaceutical Preparations | 626 out of 1,536 | 59th |
Source: SEC filing on April 26, 2022.
Robertson's colleagues
We found two more compensation records of executives who worked with Scott Robertson at DICE Therapeutics in 2021.